The many ways AI is shaping the future of healthcare

Image source: lawandfuturetechnology.lawschoolblogplatform.com

Poised to become a transformational force in the healthcare industry, artificial intelligence is shaping the future of medicine. Scientists, doctors, mathematicians, clinicians, and engineers are working together to compile data and develop machine-learning research.

The mortality rate has been reduced as AI assists and improves healthcare practices. This is the outcome of the processes of disease prevention, accurate and effective treatments, and lessons from previous knowledge. Integral to these steps is the evaluation of outcomes and processing of data. Through the introduction of systems clinicians can access by means of AI, urgent medical cases can be prioritized. Playing a bigger role in medical care, AI can also assist in recommending individualized treatments.

Fast and precise diagnoses are available, as systems are ready to mete medical advice to patients, whether in a medical facility or at home. Artificial intelligence can take over some of the diagnostic duties usually assigned to humans to mitigate the grave deficit of qualified clinical staff, especially in developing nations.

Image source: aexonic.com

More and more smart medical devices and machines are being fabricated, as these are crucial for monitoring patients in the ICU and remotely. AI enhances the ability of a device to identify deterioration and the onset of sepsis and locate complications.

Immunotherapy for cancer treatment has been a significant beneficiary of AI methods. It is the most promising method for treating cancer. Patients may be able to beat stubborn tumors by using their body’s own immune system to assault malignancies. However, more patient data is needed to confirm the effectiveness of the relatively new treatment method.

Alex J. Ness is the Executive Chairman and Co-founder of Welwaze Medical, Inc., a health tech company that develops external sensors which allow users to monitor their health. Artificial intelligence is at the core of the company’s development. For more updates on artificial intelligence, visit this blog.

Better Breast Cancer Diagnosis Through Ai

In the recent years, the diagnosis and treatment of breast cancer have taken huge steps, all due to many ongoing studies toward its improvement. Treatment and diagnosis are more advanced than before and have gotten more accurate, leading to better results in patients.

Early detection and treatment are displayed to lead better outcomes for women with cancer, yet precisely detecting and diagnosing breast cancer stays extremely challenging. An x-ray of the breasts, or a mammogram, is used by clinicians to determine cancers early, but breast screening is not exact. Per year, thousands of cases are not picked up by mammograms, which include 30 percent of cancers that develop in the middle of screenings, while instances of overdiagnosis or false alarms are usual.

Breast cancer is the most common type of cancer among women around the world. It is also the most diagnosed cancer in women and the second leading cause of death in women in the United States. A woman is diagnosed with breast cancer every two minutes, and every 13 minutes, one woman dies from it.

Image source: Chicago.suntimes.com

Having these facts in mind, Welwaze Medical, Inc, has developed Celbrea TMD, which is a safe, reliable, and affordable way to routinely monitor for breast abnormalities, including breast cancer. It is a non-invasive test that can be used for breast self-exams at home when prescribed by doctors. Celbrea TMD was developed and designed to help detect breast diseases by recording the temperature differentiation between corresponding areas of the left and the right breasts.

Alex J. Ness is the Executive Chairman of Welwaze Medical, Inc, a health tech company that develops external sensors that allow users to monitor their health. Since 2016, Welwaze has acquired intellectual property for its revolutionary early breast cancer detection device. For more articles like this, follow this page.